EUVIMEDEUVIMED entdecken
Crossref

Adverse Drug Reactions of Antihypertensive Drugs in Pregnancy: A Comprehensive Study - A Review

Vaishnavi M Mahamuni, Abhirup R Sagare, Prakash D Jadhav, Harshada S Yadav, Vaishnavi S Veer, Akshada S Padalkar, Vaishnavi B Kadam

International Journal of Pharmaceutical Sciences Review and Research · 2026-06 · 86 (6)

DOI: 10.47583/ijpsrr.2026.v86i6.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences Review and Research, 2026-06. Verfasst von Vaishnavi M Mahamuni und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antihypertensive medication-related adverse drug reactions (ADRs) during pregnancy are a serious concern since they may have an impact on the development of the fetus as well as the health of the mother.A considerable percentage of pregnancies are complicated by hypertensive conditions such gestational hypertension, preeclampsia, and chronic hypertension, which frequently call for pharmacological treatment.Labetalol, methyldopa, nifedipine, and hydralazine are common antihypertensive medications; however, their safety profiles varies depending on the stage of pregnancy.While some medications are thought to be reasonably safe, others may cause fetal problems such intrauterine growth restriction, preterm birth, and congenital abnormalities, as well as negative maternal effects like hypotension, exhaustion, and electrolyte imbalance.Notably, because of their link to severe fetal toxicity, some classes, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), are prohibited.The purpose of this research is to critically assess the prevalence, mechanisms, and risk factors related to adverse drug reactions (ADRs) of antihypertensive medications during pregnancy.In order to reduce possible hazards, it also emphasizes the significance of careful medication selection, dose adjustment, and ongoing monitoring.To give a thorough understanding of drug safety in this population, evidence from clinical research, pharmacovigilance databases, and treatment guidelines is reviewed.In order to effectively manage hypertension during pregnancy and enhance mother and fetal outcomes, the review highlights the necessity of tailored therapy and greater knowledge among healthcare professionals.

Zitieren

APA

Mahamuni, V. M., Sagare, A. R., Jadhav, P. D., Yadav, H. S., Veer, V. S., Padalkar, A. S., & Kadam, V. B. (2026). Adverse Drug Reactions of Antihypertensive Drugs in Pregnancy: A Comprehensive Study - A Review. International Journal of Pharmaceutical Sciences Review and Research, 86(6). https://doi.org/10.47583/ijpsrr.2026.v86i6.022

Vancouver

Mahamuni VM, Sagare AR, Jadhav PD, Yadav HS, Veer VS, Padalkar AS, et al. Adverse Drug Reactions of Antihypertensive Drugs in Pregnancy: A Comprehensive Study - A Review. International Journal of Pharmaceutical Sciences Review and Research. 2026;86(6). doi:10.47583/ijpsrr.2026.v86i6.022

BibTeX
@article{Mahamuni2026,
  author = {Mahamuni, Vaishnavi M and Sagare, Abhirup R and Jadhav, Prakash D and Yadav, Harshada S and Veer, Vaishnavi S and Padalkar, Akshada S and Kadam, Vaishnavi B},
  title = {Adverse Drug Reactions of Antihypertensive Drugs in Pregnancy: A Comprehensive Study - A Review},
  journal = {International Journal of Pharmaceutical Sciences Review and Research},
  year = {2026},
  volume = {86},
  number = {6},
  doi = {10.47583/ijpsrr.2026.v86i6.022}
}
Kostenlos starten →